Showing results (1151-1160 of 6,501) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 3, 2021
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitorsShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2020
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLCMarzia Del Re, Federico Cucchiara, Eleonora Rofi, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2020
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature reviewAasir M Suliman, Shaza A Bek, Mohamed S Elkhatim, et al.
Cancer Immunology, Immunotherapy : CII|October 31, 2020
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapyAyaka Hara, Ryo Koyama-Nasu, Mariko Takami, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancerGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri
Cancer Immunology, Immunotherapy : CII|September 8, 2022
Anti-PD-1 antibody-activated Th17 cells subvert re-invigoration of antitumor cytotoxic T-lymphocytes via myeloid cell-derived COX-2/PGE2Qingsheng Li, Kevin E Goggin, SeonYeong Seo, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 2022
Live attenuated VZV vaccination induces antitumor immunity in ATLL patientsTatsuro Jo, Ritsuko Kubota-Koketsu, Yohei Kaneko, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2021
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world settingZhaozhen Wu, Haitao Tao, Sujie Zhang, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patientRunbo Zhong, Yunbin Zhang, Dongfang Chen, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesisSabrina Traxel, Julia Lehmann, Stefanie Richard, et al.
Pageof 651